Pluristem Therapeutics Stock Price - PSTI

-0.07 (-1.68%)
Upgrade to Real-Time
Regular Market
Best deals to access real time data!
Canadian Level 1 + USA
Monthly Subscription
for only
CHART Trader
Monthly Subscription
for only
Big Cap Pro
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Pluristem Therapeutics Inc PSTI NASDAQ Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
-0.07 -1.68% 4.10 4.00 4.16 4.14 4.17 14:04:52
Bid Price Ask Price Spread Spread % News
4.08 4.10 0.02 0.49% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
424 87,710 $ 4.10 $ 359,307 150,199 3.11 - 10.40
Last Trade Time Type Quantity Stock Price Currency
14:04:52 100 $ 4.10 USD

Pluristem Therapeutics Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 74.13M 17.86M $ -26.13M -29.02 - 1.72M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Pluristem Therapeutics News

Date Time Source News Article
2/10/202007:00GlobeNewswire Inc.Pluristem Therapeutics CEO Issues Shareholder Update
2/06/202016:11Edgar (US Regulatory)Quarterly Report (10-q)
2/03/202007:00GlobeNewswire Inc.In Its Path Towards Marketing, Pluristem Provides Highly..
12/17/201907:00GlobeNewswire Inc.Pluristem Completes 75% Enrollment in its Pivotal Phase III..
12/03/201907:00GlobeNewswire Inc.Pluristem Reaches Milestone in its Phase III Muscle Injury..
11/12/201907:00GlobeNewswire Inc.Pluristem Therapeutics CEO Issues Shareholder Update
11/07/201916:11Edgar (US Regulatory)Quarterly Report (10-q)

Latest PSTI Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical PSTI Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week4.624.654.004.42130,757-0.52-11.26%
1 Month3.795.173.59244.29136,3200.318.18%
3 Months3.635.173.384.02160,6020.4712.95%
6 Months3.705.173.113.9199,0960.4010.81%
1 Year10.4010.403.115.90291,346-6.30-60.58%
3 Years11.2021.203.1111.38327,058-7.10-63.39%
5 Years30.7032.803.1112.71280,139-26.60-86.64%

Pluristem Therapeutics Description

Pluristem Therapeutics Inc is a US-based company which acts as a developer of placenta-based cell therapy product candidates for the treatment of multiple ischemic, inflammatory and hematologic conditions. The lead indications are critical limb ischemia, recovery after surgery for femoral neck fracture, and acute radiation syndrome. The company operations are focused on the research, development, clinical trials and manufacturing of cell therapeutics and related technologies. Pluristem operates through the single business segment being Development of placenta-based cell therapy product.
Your Recent History
Pluristem ..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20200225 19:21:01